The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 85, Issue 1, Pages 37-46
Publisher
Wiley
Online
2018-10-06
DOI
10.1111/bcp.13780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
- (2018) Chih-Cheng Hsu et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
- (2017) Chen-Pin Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study
- (2017) John J. Bissler et al. PLoS One
- Metformin Protects Neurons against Oxygen-Glucose Deprivation/Reoxygenation -Induced Injury by Down-Regulating MAD2B
- (2016) Xianfang Meng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma
- (2016) Talita Antunes Guimarães et al. Oncotarget
- Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study
- (2016) Patricia Hafner et al. PLoS One
- Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
- (2016) David N. Franz et al. PLoS One
- Dystrophin–glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling
- (2015) Joanne F. Garbincius et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
- (2014) Mihaela Aldea et al. TUMOR BIOLOGY
- Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation
- (2013) Olga Moiseeva et al. AGING CELL
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Metformin limits ceramide-induced senescence in C2C12 myoblasts
- (2013) Kavita S. Jadhav et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
- (2013) Yanfei Zhang et al. PLoS One
- Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
- (2013) David Preiss et al. Lancet Diabetes & Endocrinology
- Targeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program
- (2012) Ronald B. Goldberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- O-Carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells
- (2012) K.S. Snima et al. CARBOHYDRATE POLYMERS
- Renal tumours in a Tsc1+/– mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
- (2012) Jian Yang et al. EUROPEAN JOURNAL OF CANCER
- Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles
- (2012) Rohit Bhandari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival
- (2012) Alejo Efeyan et al. NATURE
- Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)
- (2012) Neil Auricchio et al. PLoS One
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs
- (2011) C. Ll. Morgan et al. DIABETES OBESITY & METABOLISM
- Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle
- (2011) V. Ljubicic et al. HUMAN MOLECULAR GENETICS
- Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft
- (2011) Jun Liu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- AMPK-mediated regulation of transcription in skeletal muscle
- (2010) Sean L. McGee et al. CLINICAL SCIENCE
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation
- (2010) Junyu Ning et al. MOLECULAR ENDOCRINOLOGY
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Perinatal (Fetal and Neonatal) Tuberous Sclerosis: A Review
- (2009) Hart Isaacs AMERICAN JOURNAL OF PERINATOLOGY
- Therapeutic targeting of mTOR in tuberous sclerosis
- (2009) Julian R. Sampson BIOCHEMICAL SOCIETY TRANSACTIONS
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
- (2009) Kristen Pollizzi et al. Molecular Cancer
- The relationship among tumor architecture, pharmacokinetics, pharmacodynamics, and efficacy of bortezomib in mouse xenograft models
- (2009) M. J. Williamson et al. MOLECULAR CANCER THERAPEUTICS
- Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study
- (2008) F J K O'Callaghan et al. ARCHIVES OF DISEASE IN CHILDHOOD
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- Important role of the LKB1–AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
- (2008) Xu Huang et al. BIOCHEMICAL JOURNAL
- The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
- (2008) G.F.L. Hofbauer et al. BRITISH JOURNAL OF DERMATOLOGY
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Sirolimus Therapy in Tuberous Sclerosis or Sporadic Lymphangioleiomyomatosis
- (2008) D. Mark Davies et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now